Published in J Cell Biol on January 01, 1992
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell (1993) 4.33
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev (2003) 3.48
Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest (2003) 3.31
CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol (1995) 2.38
Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J (1993) 1.74
Structural and functional studies on platelet-derived growth factor. EMBO J (1992) 1.64
Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci U S A (1993) 1.63
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 1.25
The extracellular regulation of growth factor action. Mol Biol Cell (1992) 1.25
Brain extracellular matrix in neurodegeneration. Brain Pathol (2008) 1.15
Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am J Pathol (2002) 1.15
Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest (1994) 1.14
Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol (1998) 1.13
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev (2002) 1.12
The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr Rev (2010) 1.11
PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly. J Cell Biol (1992) 1.09
Development and postnatal regulation of adult myoblasts. Microsc Res Tech (1995) 1.07
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol (1993) 1.06
Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Invest (1993) 1.06
Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix. J Cell Biol (1993) 1.00
Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells. Am J Pathol (1997) 0.96
CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels. FEBS Lett (2006) 0.94
Engineering insulin-like growth factor-1 for local delivery. FASEB J (2008) 0.92
Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest (1993) 0.90
Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease. Crit Care (2006) 0.90
Regulation of the spatial organization of mesenchymal connective tissue: effects of cell-associated versus released isoforms of platelet-derived growth factor. Am J Pathol (1999) 0.87
Loop III region of platelet-derived growth factor (PDGF) B-chain mediates binding to PDGF receptors and heparin. Biochem J (1998) 0.86
The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoprotein. J Cell Biol (1993) 0.86
Mistranslation of a TGA termination codon as tryptophan in recombinant platelet-derived growth factor expressed in Escherichia coli. Biochem J (1995) 0.85
Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med (2016) 0.85
Loss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity. Am J Physiol Endocrinol Metab (2011) 0.84
The process of atherogenesis--cellular and molecular interaction: from experimental animal models to humans. Diabetologia (1992) 0.82
Mesoderm layer formation in Xenopus and Drosophila gastrulation. Phys Biol (2011) 0.81
Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans. Histochem Cell Biol (2003) 0.81
Analysis of mice lacking the heparin-binding splice isoform of platelet-derived growth factor A. Mol Cell Biol (2013) 0.80
The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis. Am J Pathol (1998) 0.77
Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer. World J Gastroenterol (2005) 0.77
Angiogenic growth factors in myocardial infarction: a critical appraisal. Heart Fail Rev (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71
A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem (1974) 13.32
Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (1989) 8.10
A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell (1990) 6.08
Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis (1989) 5.88
A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell (1988) 5.42
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry (1979) 5.02
Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A (1987) 4.83
cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature (1986) 4.81
Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science (1989) 4.08
A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol (1988) 3.72
Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59
Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem (1989) 3.33
Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science (1990) 3.27
Platelet-derived growth factor. II. Specific binding to cultured cells. J Biol Chem (1982) 3.20
Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J (1988) 3.16
Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia. Proc Natl Acad Sci U S A (1981) 3.02
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science (1990) 3.02
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98
Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science (1983) 2.97
Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol (1988) 2.84
Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell (1989) 2.65
Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. J Biol Chem (1989) 2.59
Temperature-sensitive steps in the transport of secretory proteins through the Golgi complex in exocrine pancreatic cells. Proc Natl Acad Sci U S A (1986) 2.58
The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell (1989) 2.49
Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature (1987) 2.40
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol (1990) 2.33
Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J (1990) 2.17
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell (1990) 2.10
Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun (1987) 2.08
Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. J Cell Biol (1989) 1.97
Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun (1989) 1.91
Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci U S A (1988) 1.87
The v-sis/PDGF-2 transforming gene product localizes to cell membranes but is not a secretory protein. EMBO J (1985) 1.72
Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol Cell Biol (1987) 1.71
Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells. J Cell Biol (1983) 1.66
Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes. Cell (1988) 1.59
Structural characterization of the human platelet-derived growth factor A-chain cDNA and gene: alternative exon usage predicts two different precursor proteins. Mol Cell Biol (1988) 1.55
Alternative RNA splicing affects function of encoded platelet-derived growth factor A chain. Nature (1987) 1.50
Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science (1988) 1.47
Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry (1990) 1.46
The alternatively spliced exon of the platelet-derived growth factor A chain encodes a nuclear targeting signal. Mol Cell Biol (1989) 1.45
Expression of three recombinant homodimeric isoforms of PDGF in Saccharomyces cerevisiae: evidence for difference in receptor binding and functional activities. Growth Factors (1989) 1.45
Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J Cell Biochem (1991) 1.45
Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci U S A (1990) 1.40
Methods for studying the platelet-derived growth factor receptor. Methods Enzymol (1985) 1.40
Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. Proc Natl Acad Sci U S A (1989) 1.39
Identification of a signal for nuclear targeting in platelet-derived-growth-factor-related molecules. Mol Cell Biol (1987) 1.38
cDNA clones reveal differences between human glial and endothelial cell platelet-derived growth factor A-chains. Nature (1987) 1.38
Platelet-derived growth factor A chain is maternally encoded in Xenopus embryos. Science (1988) 1.37
A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes Dev (1991) 1.36
Purification of human platelet-derived growth factor. Methods Enzymol (1985) 1.36
Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain. Cell Regul (1991) 1.34
Prohormone processing and the secretory pathway. J Biol Chem (1988) 1.20
Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF. Growth Factors (1990) 1.19
Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product. Proc Natl Acad Sci U S A (1985) 1.18
Analogous alternative splicing. Nature (1990) 1.12
Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects. Mol Cell Biol (1988) 1.12
Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-alpha. Nature (1987) 1.09
Detection of PDGF-2 homodimers in human tumor cells. Oncogene (1987) 1.05
Molecular localization of the transforming and secretory properties of PDGF A and PDGF B. Science (1990) 1.05
Polylysine-containing peptides, including the carboxyl-terminal segment of the human c-Ki-ras 2 protein, affect the activity of some key membrane enzymes. Proc Natl Acad Sci U S A (1987) 1.03
Generation of transforming growth factor-alpha from the cell surface by an O-glycosylation-independent multistep process. J Biol Chem (1990) 1.02
Radioimmunoassay of human platelet-derived growth factor using monoclonal antibody toward a synthetic 73-97 fragment of its B-chain. Clin Chim Acta (1989) 0.97
Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation. J Biol Chem (1990) 0.93
Alternative splicing of the platelet-derived growth factor A-chain transcript occurs in normal as well as tumor cells and is conserved among mammalian species. Mol Cell Biol (1989) 0.90
In vitro tyrosine phosphorylation studies on RAS proteins and calmodulin suggest that polylysine-like basic peptides or domains may be involved in interactions between insulin receptor kinase and its substrate. Proc Natl Acad Sci U S A (1989) 0.90
Partially transformed, anchorage-independent human diploid fibroblasts result from overexpression of the c-sis oncogene: mitogenic activity of an apparent monomeric platelet-derived growth factor 2 species. Mol Cell Biol (1988) 0.89
Highly purified fibroblast-derived growth factor, an SV40-transformed fibroblast-secreted mitogen, is closely related to platelet-derived growth factor. EMBO J (1985) 0.85
Alternatively spliced platelet-derived growth factor A-chain transcripts are not tumor specific but encode normal cellular proteins. Mol Cell Biol (1990) 0.83
Amphiphilic cationic peptides mediate cell adhesion to plastic surfaces. J Cell Physiol (1985) 0.80
Melittin interactions with adenylate cyclase. Biochim Biophys Acta (1977) 0.79
The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59
The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol (1971) 10.72
A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A (1974) 9.94
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb (1994) 8.54
The biology of platelet-derived growth factor. Cell (1986) 7.17
Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol (1975) 6.42
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science (1973) 6.38
The pathogenesis of atherosclerosis (second of two parts). N Engl J Med (1976) 5.48
Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) (2000) 5.24
The pathogenesis of atherosclerosis (first of two parts). N Engl J Med (1976) 5.22
The smooth muscle cell in culture. Physiol Rev (1979) 5.03
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) (1998) 5.01
A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell (1985) 4.81
The platelet-derived growth factor. Cell (1978) 4.77
The elastic fiber. I. The separation and partial characterization of its macromolecular components. J Cell Biol (1969) 4.51
Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol (1986) 4.51
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis (1984) 4.40
Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (1991) 4.27
A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol (1976) 3.86
The fibroblast and wound repair. Biol Rev Camb Philos Soc (1968) 3.78
The fine structure of elastic fibers. J Cell Biol (1966) 3.68
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol (1998) 3.66
Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59
Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) (2000) 3.54
Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol (1976) 3.48
Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J Biol Chem (1982) 3.35
Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem (1989) 3.33
Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) (2000) 3.31
Platelet-derived growth factor. II. Specific binding to cultured cells. J Biol Chem (1982) 3.20
Wound healing and collagen formation. V. Quantitative electron microscope radioautographic observations of proline-H3 utilization by fibroblasts. J Cell Biol (1965) 3.18
Experimental arteriosclerosis. I. Fibrous plaque formation in primates, an electron microscope study. J Exp Med (1972) 3.17
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04
PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol (1990) 3.04
Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98
Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins. Cell (1982) 2.92
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res (1988) 2.90
TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell (1990) 2.82
Coordinate control of 3T3 cell proliferation by platelet-derived growth factor and plasma components. Proc Natl Acad Sci U S A (1978) 2.80
Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem (1981) 2.77
The smooth muscle cell. I. In vivo synthesis of connective tissue proteins. J Cell Biol (1971) 2.74
Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr (2000) 2.71
Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest (1990) 2.70
Development and testing of nursing home quality indicators. Health Care Financ Rev (1995) 2.68
The development of the rat flexor digital tendon, a fine structure study. J Ultrastruct Res (1967) 2.61
Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci U S A (1984) 2.58
Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55
Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell (1996) 2.55
Hyperlipidemia and atherosclerosis. Science (1976) 2.55
Human wound repair. I. Epidermal regeneration. J Cell Biol (1968) 2.39
Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation (2000) 2.38
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol (1981) 2.33
Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci U S A (1993) 2.31
Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell (1998) 2.29
Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol (1984) 2.29
Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis (1986) 2.27
Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst (1986) 2.27
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest (1995) 2.23
Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A (1986) 2.20
Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor. J Cell Biol (1978) 2.16
Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell (1988) 2.13
Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol (1968) 2.11
Response to injury and atherogenesis. Am J Pathol (1977) 2.09
Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod (2010) 2.07
Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A. Cell (1981) 2.06
Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci U S A (1988) 2.06
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98
Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest (1994) 1.97
The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest (1972) 1.96
The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A (1992) 1.94
An endothelial cell-derived growth factor. J Cell Biol (1980) 1.93
Effects of antimicrotubular agents on the secretion of collagen. A biochemical and morphological study. J Cell Biol (1974) 1.93
Economic status and survival of cancer patients. Cancer (1977) 1.93
Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima. J Cell Biol (1975) 1.93
George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis (1982) 1.90
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med (1995) 1.90
Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis (1984) 1.88
Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell (1998) 1.87
Physiological quiescence in plasma-derived serum: influence of platelet-derived growth factor on cell growth in culture. J Cell Physiol (1978) 1.85
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation (1992) 1.82
Platelet-derived growth factor. III. Identification of a platelet-derived growth factor receptor by affinity labeling. J Biol Chem (1982) 1.79
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79
The elastic fiber. J Histochem Cytochem (1973) 1.79
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med (1994) 1.78
Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J Cell Biol (1970) 1.77
Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol (1999) 1.70
Interactions between the receptors for platelet-derived growth factor and epidermal growth factor. J Cell Biol (1983) 1.68
Fine structural changes in uterine smooth muscle and fibroblasts in response to estrogen. J Cell Biol (1967) 1.68
Human body composition: advances in models and methods. Annu Rev Nutr (1997) 1.67
PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell (1991) 1.67
Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol (1987) 1.67
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1987) 1.63
Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group. J Am Coll Cardiol (1990) 1.62
Proteoglycans in primate arteries. II. Synthesis and secretion of glycosaminoglycans by arterial smooth muscle cells in culture. J Cell Biol (1975) 1.60
HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol (1987) 1.58